Mandate

Vinge advises Oy Karl Fazer Ab

June 16, 2008

Vinge advises Oy Karl Fazer Ab (“Fazer”) in connection with the contemplated de-merger of Cloetta Fazer AB (publ) (“Cloetta Fazer”) that was announced in a press release today. Through the de-merger, Cloetta Fazer creates the two future companies Cloetta and Fazer Confectionery. The new Cloetta intends to apply for a listing on the OMX Nordic Exchange Stockholm. Fazer Confectionery, i.e. the remaining Cloetta Fazer, will be consolidated in the privately held Fazer Group.

The de-merger will be carried out in several steps. Initially, the new Cloetta will be distributed as dividend to the shareholders in Cloetta Fazer. The distribution of shares as dividend is carried out according to the so-called Lex ASEA rules.

Furthermore, Fazer announces a public offer to the shareholders of the remaining Cloetta Fazer. The offer consists of a cash part of SEK 202 and 0.92 shares of class B in the new Cloetta for each share in Cloetta Fazer, which upon full acceptance in the Offer represents a consideration of in total approximately SEK 2.5 billion and approximately 11.5 million shares of class B in the new Cloetta. The intention is to successfully complete the de-merger by January 2009.

The partners Göran Nyström, Fredrik Dahl and Mattias Schömer together with the associates Dain Nevonen and Emil Hedberg advise Fazer in connection with the de-merger of the current Cloetta Fazer and the public offer to the shareholders in the remaining Cloetta Fazer.

Related

Vinge advises ABGSC in connection with EQL Pharma’s inaugural bond issuance

Vinge has advised ABG Sundal Collier in connection with EQL Pharma AB (publ)’s ( “EQL”) inaugural issuance of SEK 350,000,000 senior secured bonds within a framework of up to SEK 700,000.
January 24, 2025

Vinge represents Sedana Medical AB in the acquisition of Innovatif Cekal

Vinge has represented Sedana Medical AB (publ) in connection with the acquisition of Innovatif Cekal. Innovatif Cekal, based in Klang near Kuala Lumpur, Malaysia, is a manufacturer of medical devices. This acquisition enhances Sedana Medical's control over its supply chain and improves profitability through reduced cost of goods.
January 22, 2025

Vinge advises Infranity in connection with the acquisition of Nordic Re-Finance AB

Vinge has advised Infranity, a private equity firm specializing in infrastructure investments, in connection with its acquisition of a majority stake in Nordic Re-Finance AB, a Scandinavian locomotives lessor. The acquisition brings ambitious development plans for Nordic Re-Finance AB, including expansion into new geographical areas.
January 20, 2025